# Lesley A. Inker

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lesley-a-inker/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,021 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 80 |
| i10-index | 240 |
| Last Known Institution | Tufts Medical Center |
| OpenAlex ID | https://openalex.org/A5054296834 |
| ORCID iD | https://orcid.org/0000-0003-2820-9482 |
| Works | 447 |

## Researcher papers

Showing 12 of 15.

- [Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019](https://scholariq.org/papers/global-burden-of-cardiovascular-diseases-and-risk-factors-1990-2019/)
- [KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2024-clinical-practice-guideline-for-the-evaluation-and-management-of/)
- [Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C](https://scholariq.org/papers/estimating-glomerular-filtration-rate-from-serum-creatinine-and-cystatin-c/)
- [KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2012-kdigo-clinical-practice-guideline-for-the/)
- [Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality](https://scholariq.org/papers/decline-in-estimated-glomerular-filtration-rate-and-subsequent-risk-of-end-stage/)
- [Cystatin C versus Creatinine in Determining Risk Based on Kidney Function](https://scholariq.org/papers/cystatin-c-versus-creatinine-in-determining-risk-based-on-kidney-function/)
- [Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference](https://scholariq.org/papers/nomenclature-for-kidney-function-and-disease-report-of-a-kidney-disease/)
- [Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure](https://scholariq.org/papers/multinational-assessment-of-accuracy-of-equations-for-predicting-risk-of-kidney/)
- [Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency](https://scholariq.org/papers/change-in-albuminuria-and-gfr-as-end-points-for-clinical-trials-in-early-stages/)
- [Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)](https://scholariq.org/papers/drug-dosing-consideration-in-patients-with-acute-and-chronic-kidney-disease-a/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns](https://scholariq.org/papers/executive-summary-of-the-kdigo-2024-clinical-practice-guideline-for-the-3/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Tufts Medical Center](https://scholariq.org/institutions/tufts-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.